Stay updated on ENLIVEN Trial Assessing BIO89-100 in NASH
Sign up to get notified when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.

Latest updates to the ENLIVEN Trial Assessing BIO89-100 in NASH page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA notice about NIH’s terminology transition appears above the ClinicalTrials.gov error page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check29 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the usual content with an access-denied message, indicating a server or permission issue rather than a data update.SummaryDifference18%

- Check50 days agoChange DetectedThe page now shows Revision: v3.7.0 (instead of v3.6.6), reflecting a software release/version update. This change communicates a backend/UI update without altering study content or conclusions.SummaryDifference0.0%

- Check64 days agoChange Detected- Revision metadata updated from v3.6.5 to v3.6.6, reflecting a newer page version. This appears to be a backend/versioning update and does not modify study content or public-facing information.SummaryDifference0.0%

Stay in the know with updates to ENLIVEN Trial Assessing BIO89-100 in NASH
Enter your email address, and we'll notify you when there's something new on the ENLIVEN Trial Assessing BIO89-100 in NASH page.